ERAS vs EXEL Stock Comparison
EXEL currently leads ERAS in this stock comparison, with AIQ scores of 82 vs 61. The clearest difference is risk resilience.
What is the main difference between ERAS and EXEL?
EXEL leads the current stock comparison as Exelixis, Inc., with the clearest separation coming from risk resilience and the broader AIQ evidence mix.
AlgovestIQ AIQ Comparison
Erasca, Inc. vs Exelixis, Inc.
EXEL leads
EXEL leads by 21 AIQ points, primarily on Risk Resilience and Momentum, but the lead has narrowed from 39 points over 30 sessions.
Competitive: 4 of 4 evidence groups support EXEL, its lead is narrowing, and its current signal state is conflicted.
Erasca, Inc.
Exelixis, Inc.
The Algovestiq AIQ Score currently favors EXEL over ERAS, 82 versus 61 as of Nov 15, 2026. EXEL's advantage is driven primarily by stronger risk resilience and momentum. EXEL also shows the stronger technical structure relative to its 50-day moving average. 4 of 4 covered evidence groups favor EXEL today, and the comparison is rated Competitive on stability: the leader's advantage has been narrowing. EXEL lead: Weakening — the AIQ differential moved from 39 to 21 points over 30 sessions.
Compare Erasca, Inc. and Exelixis, Inc. across the Algovestiq AIQ Score, valuation, quality, momentum, risk, technicals and analyst expectations.
Performance over time
Price return from daily closes; distributions are not included.
Price return comparison
Growth of $10,000, price only
Split-adjusted closes only. Distributions are excluded, which understates the return of any fund or stock that pays them.
Compare ERAS and EXEL against another ticker
Open a multi-ticker workspace without changing this focused pair page.
AIQ Factor Divergence
Where the two separate, on the four dimensions behind the AIQ Score. Bars read outward from a shared zero: further from the centre is a wider gap.
- Risk Resilience39 vs 77EXEL +38
- Momentum67 vs 91EXEL +24
- Quality65 vs 75EXEL +10
4 of 4 evidence groups favor EXEL. EXEL’s edge is concentrated in risk resilience and momentum.
What changed since the last close
Latest scored session 2026-11-13, compared against the prior scored session 2026-11-12.
Largest factor move: Quality +21
New signals
- ADX Trend Weakening — neutral, trend, medium horizon
- Accumulation Pattern — bullish, volume, medium horizon (1.70x)
Largest factor move: Value +1, not enough on its own to move the overall score.
No signal started or stopped since the prior session; its 6 active signals are unchanged.
EXEL's lead narrowed by 9 AIQ points in the latest session.
Deeper signal detail for each name lives on its own signals page — ERAS and EXEL both carry a full feed there.
Which one fits your objective
The same two names rank differently depending on what you are optimizing for. All six reads are shown at once — none of them is hidden behind a toggle.
Balanced
EXELEXEL on the overall AIQ Score, which weights Quality and Value most heavily.
Growth
EXELEXEL on combined revenue and EPS growth.
Value
EvenThe two are level on Value.
Momentum
EXELEXEL on the Momentum factor, by 24 points.
Lower downside
EXELEXEL on Risk Resilience, by 38 points.
Analyst upside
EvenAnalyst targets are level or not covered for both names.
AIQ vs Wall Street
Where the systematic read and the analyst consensus line up — and where they do not.
| Measure | ERAS | EXEL | Note |
|---|---|---|---|
| Implied upside to target | — | -15% | Level |
| Target dispersion | — | +23.9% | Lower is tighter analyst agreement |
| Consensus | Buy | Hold | Context, not a primary driver |
| Analysts covering | 9 | 17 | Higher coverage generally improves confidence |
Analyst targets are expectations, not predictions. Dispersion matters as much as the midpoint.
AIQ Agreement Matrix
4 of 4 covered evidence groups favor EXEL. A wide gap backed by one group is a weaker case than a narrow gap backed by five.
| Evidence group | Favors | Reading |
|---|---|---|
| AIQ Score | EXEL | 61 vs 82 |
| Fundamentals | EXEL | EPS growth -7.1% vs 3.5%; TTM ROE -5.6% vs 11.9% |
| Valuation | Not covered | Not covered |
| Technicals | EXEL | Price vs 50-day 4.7% vs 10.8%; vs 200-day 2.6% vs 32.1% |
| Risk Resilience | EXEL | Risk Resilience 39 vs 77 |
| Analyst expectations | Not covered | Not covered |
✓ agrees with the overall verdict · ✕ points the other way. Groups marked “not covered” lack data on one or both of ERAS and EXEL and are excluded from the count.
AIQ Decision Stability
The two are close enough that your objective, not the score, should decide.
- The AIQ gap is wide at 21 points. (supports the conclusion holding)
- 4 of 4 covered evidence groups point the same way. (supports the conclusion holding)
- The leader's advantage has been narrowing. (argues the conclusion is provisional)
- The lead has swung materially session to session. (argues the conclusion is provisional)
- The leader is throwing conflicting signals. (argues the conclusion is provisional)
Stability combines the score gap, how broadly the evidence agrees, how steady the lead has been across daily snapshots, the current signal state on both names, and analyst dispersion on EXEL.
How the comparison changed
120 daily snapshots · May 27 – Nov 13EXEL lead: Weakening — the AIQ differential moved from 39 to 21 points over 30 sessions.
- Today
- EXEL +21
- 61 vs 82
- 7 sessions ago
- EXEL +31
- 51 vs 82
- 30 sessions ago
- EXEL +39
- 41 vs 80
- 90 sessions ago
- EXEL +15
- 59 vs 74
The lead has not changed hands in this window.
AIQ Signal Divergence
Only the signals that bear on the head-to-head. A conflicted name is carrying bullish and bearish rules at the same time — the technical evidence is not pointing one way.
2 bullish / 2 bearish / 2 neutral, conflicted
Only ERAS
- Death Cross Active — bearish, trend, long horizon (2.00%)
- ADX Trend Weakening — neutral, trend, medium horizon
- ATR Expansion - Breakout Mode — neutral, volatility, short horizon (7.83%)
- Accumulation Pattern — bullish, volume, medium horizon (1.70x)
- Beta Spike Warning — bearish, risk_regime, long horizon
3 bullish / 3 bearish, conflicted
Only EXEL
- Golden Cross Active — bullish, trend, long horizon (19.22%)
- Low Volume Rally Warning — bearish, volume, short horizon (0.54x)
- MACD Histogram Expanding Bearish — bearish, momentum, short horizon
- RSI Bearish Divergence — bearish, momentum, medium horizon
- Uptrend Structure Active — bullish, trend, long horizon
Both carry 1 more signal that do not separate them: EMA Ribbon Expansion Bullish.
EXEL leads the comparison while carrying a conflicted signal state, which is one reason the stability rating is not higher.
Price vs model alignment
Whether the latest session's price move confirms what the model did over the same session, or contradicts it.
Price is down while the AIQ Score moved up 9 points over the same session — price and model disagree (price -0.76%, AIQ +9 points).
Neither the price nor the AIQ Score moved enough in the latest session to confirm or contradict the other (price -1.2%, AIQ 0 points).
What would flip this result
A state, not a forecast. These are the specific, observable changes that would reverse the verdict — not a price prediction.
- 1ERAS closes the Risk Resilience gap — currently 38 points behind, the largest single contributor to EXEL's edge.
- 2ERAS's Death Cross Active resolves — a bearish trend rule currently active against it.
- 3EXEL's conflicting signal state resolves bearish — it currently carries 3 bullish and 3 bearish rules at once.
- 4The narrowing continues — the lead has already given back 18 points over 30 sessions, and a further 21-point move would eliminate EXEL's advantage entirely.
The full evidence
Every number behind the verdict. The leader is called above each group so you are not left to solve it from the table.
Fundamentals
EXEL leads on balance| Metric | ERAS | EXEL |
|---|---|---|
| Revenue growth (YoY) | 0% | 4.8% |
| EPS growth (YoY) | -7.1% | 3.5% |
| Gross margin | 0% | 96.3% |
| Operating margin | 0% | 40.2% |
| Return on equity (TTM) | -5.6% | 11.9% |
| Debt to equity | 0.05 | 0.09 |
Performance
ERAS leads 5 of 6 windows| Metric | ERAS | EXEL |
|---|---|---|
| 1 week (5 sessions) | 8.7% | -0.8% |
| 1 month (20 sessions) | 17% | 10.9% |
| 3 months (63 sessions) | -14.3% | 31.9% |
| 6 months (126 sessions) | 53.1% | 37.6% |
| Year to date | 321% | 57.4% |
| 1 year (252 sessions) | 490.9% | 58.3% |
Technicals
EXEL has the stronger structure| Metric | ERAS | EXEL |
|---|---|---|
| RSI (14) | 53.8 | 58.6 |
| ADX (14) | 11.6 | 40.8 |
| Price vs 50-day | 4.7% | 10.8% |
| Price vs 200-day | 2.6% | 32.1% |
| Volatility (1M, annualized) | 81.1% | 34.5% |
Risk
EXEL is the more resilient| Metric | ERAS | EXEL |
|---|---|---|
| Beta | 1.62 | 0.61 |
| Sharpe ratio | 2.29 | 1.5 |
| Sortino ratio | 3.65 | 2.32 |
| Max drawdown | -59.5% | -12.6% |
| Current drawdown | -30.3% | -5.2% |
| Annualized volatility | 102.7% | 33.9% |
| Value at risk (95%) | -6.6% | -2.8% |
Straight answers
Each answer is regenerated from the current snapshot, not written once and left to age.
Which is better, ERAS or EXEL?
On the Algovestiq AIQ Score, EXEL is the stronger of the two as of Nov 15, 2026, scoring 82 against ERAS's 61. The edge comes from risk resilience and momentum. This is a systematic score, not a recommendation: it ranks the two on the same evidence, it does not know your holding period or tax position.
Is ERAS or EXEL the better buy right now?
EXEL carries the stronger systematic profile as of Nov 15, 2026, and the comparison is rated Competitive — 4 of 4 covered evidence groups agree. A Competitive rating means the two are close enough that your objective, not the score, should decide.
Why does the AIQ Score favor EXEL over ERAS?
The composite weights Quality, Value, Momentum and Risk Resilience. EXEL leads Risk Resilience by 38 points; EXEL leads Momentum by 24 points; EXEL leads Quality by 10 points. Where the two split, the factor with the larger weight carries the result.
Which has more analyst upside, ERAS or EXEL?
Analyst price targets imply not covered upside for ERAS and -15% for EXEL. The model and the Street agree here, which is a broader base of evidence than either alone. Analyst targets are expectations, not predictions, and dispersion matters as much as the midpoint.
Which is better value, ERAS or EXEL?
Neither name separates on the peer-relative Value factor. The two are level on Value. The Value factor reads valuation relative to sector peers and to the company's own fundamental quality, so it is not the same as simply having the lower multiple.
Which has stronger growth, ERAS or EXEL?
EXEL on combined revenue and EPS growth. Growth here is measured on reported revenue and earnings, not on forward estimates — it describes what the businesses have delivered, not what the Street expects next.
Which has stronger momentum, ERAS or EXEL?
EXEL on the Momentum factor, by 24 points. Momentum is one of the four weighted factors in the AIQ composite. It has documented persistence over three- to twelve-month horizons, which makes it a timing input rather than a reason to hold something indefinitely.
Which is riskier, ERAS or EXEL?
EXEL is the more resilient of the two, so the other name carries the higher downside risk. EXEL on Risk Resilience, by 38 points. Risk Resilience is a weighted factor in the composite; position sizing usually responds to it more usefully than the buy/avoid decision does.
Is ERAS more profitable than EXEL?
EXEL leads on the comparable margin measures — gross margin 0% vs 96.3%; operating margin 0% vs 40.2%; ttm roe -5.6% vs 11.9%.
Is EXEL's lead over ERAS getting stronger or weaker?
EXEL lead: Weakening — the AIQ differential moved from 39 to 21 points over 30 sessions. This is measured from 120 daily comparison snapshots between 2026-05-27 and 2026-11-13. The lead has not changed hands in that window.
What would change the ERAS vs EXEL verdict?
The result is a state, not a forecast, so it changes when the underlying evidence changes. Concretely: ERAS closes the Risk Resilience gap — currently 38 points behind, the largest single contributor to EXEL's edge; ERAS's Death Cross Active resolves — a bearish trend rule currently active against it; EXEL's conflicting signal state resolves bearish — it currently carries 3 bullish and 3 bearish rules at once; the narrowing continues — the lead has already given back 18 points over 30 sessions, and a further 21-point move would eliminate EXEL's advantage entirely.
What do the current signals say about ERAS and EXEL?
ERAS: 2 bullish / 2 bearish / 2 neutral, conflicted. EXEL: 3 bullish / 3 bearish, conflicted. A conflicted state means bullish and bearish rules are active on the same name at once — the technical evidence is not pointing one way, and a decision taken on it carries more timing risk. The most decision-relevant rule on ERAS is Death Cross Active (bearish, long horizon). On EXEL it is Golden Cross Active (bullish, long horizon).
Compare ERAS and EXEL with others
Continue your research
This page answers which of the two. These answer the questions on either side of it.
How this comparison is scored
The Algovestiq AIQ Score composites four factors — Quality, Value, Momentum and Risk, each carrying a fixed weight. Sentiment is reported separately as SentimentPulse and is not folded into the composite. Scores refresh every trading day, and this page regenerates from the latest snapshot rather than being written once.
The verdict names a leader, states how broadly six independent evidence groups agree, and rates how durable that conclusion is given the score gap, its recent trajectory and the current signal state on both names.
How to use side-by-side comparison →This comparison is informational and educational, not investment advice. AIQ scores update daily; re-check after earnings, guidance or macro data that materially changes either name’s factor profile.